Elimination of the Need for Urine Studies in the Screening Algorithm for Monoclonal Gammopathies by Using Serum Immunofixation and Free Light Chain Assays

Katzmann, Jerry A.; Dispenzieri, Angela; Kyle, Robert A.; Snyder, Melissa R.; Plevak, Matthew F.; Larson, Dirk R.; Abraham, Roshini S.; Lust, John A.; Melton III, L. Joseph; Rajkumar, S. Vincent
December 2006
Mayo Clinic Proceedings;Dec2006, Vol. 81 Issue 12, p1575
Academic Journal
OBJECTIVE: To determine the relative diagnostic contribution of urine assays as part of the screening algorithm for monoclonal gammopathies. PATIENTS AND METHODS: We Identified 428 patients with a monoclonal gammopathy and monoclonal urinary protein at initial diagnosis of plasma cell dyscrasia who had also undergone serum immunofixation and serum free light chain quantitation within 30 days of diagnosis. The laboratory results for serum protein electrophoresis, serum immunofixation, serum free light chain, urine protein electrophoresis, and urine immunofixation were reviewed. RESULTS: The patients had diagnoses of multiple myeloma, primary amyloid, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, solitary plasmacytomas, and other less frequently detected monoclonal gammopathies. All 428 had a monoclonal urine protein, 85.7% had an abnormal serum free light chain κ/λ ratio, 80.8% had an abnormal serum protein electrophoresis, and 93.5% had an abnormal serum immunofixation result. All 3 serum assays were normal in only 2 patients, 1 of whom had monoclonal gammopathy of undetermined significance (Idiopathic Bence Jones proteinuria) and 1 whose urine sample contained an intact monoclonal immunoglobulin but whose serum and subsequent urine samples showed no evidence of a monoclonal gammopathy. CONCLUSION: Discontinuation of urine studies and reliance on a diagnostic algorithm using only serum studies (protein electrophoresis, immunofixation, and free light chain quantitation) missed 2 (0.5%) of the 428 monoclonal gammopathies with urinary monoclonal proteins, and these 2 cases required no medical intervention.


Related Articles

  • Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma. Woitge, H W; Pecherstorfer, M; Horn, E; Keck, A-V; Diel, I J; Bayer, P; Ludwig, H; Ziegler, R; Seibel, M J // British Journal of Cancer;2/1/2001, Vol. 84 Issue 3, p344 

    To test the potential of immunoreactive BSP, a non-collagenous bone matrix component, as a clinical guide in patients with plasma cell dyscrasias, serum BSP concentrations were measured in 62 patients with newly diagnosed multiple myeloma (MM) followed over a period of 4 years, in 46 patients...

  • Verification of serum reference intervals for free light chains in a local South African population. Zemlin, Annalise E.; Rensburg, Megan A.; Ipp, Hayley; Germishuys, Jurie J.; Erasmus, Rajiv T. // Journal of Clinical Pathology;Nov2013, Vol. 66 Issue 11, p992 

    Monoclonal serum free light chain measurements are used to follow up and manage patients with monoclonal gammopathies, and abnormal serum free light chain ratios are associated with risk of progression in certain diseases. We aimed to validate the reference intervals in our population. Reference...

  • Monoclonal Gammopathy of Undetermined Significance. Bladé, Joan // New England Journal of Medicine;12/28/2006, Vol. 355 Issue 26, p2765 

    The article discusses the diagnosis, evaluation, and treatment of a patient with the clinical problem monoclonal gammopathy of undetermined significance (MGUS). An overview of MGUS is presented along with various statistical information related to its prevalence and progression. The author...

  • Serum immunoglobulin free light chain and heavy/light chain measurements in POEMS syndrome. Wang, Chen; Su, Wei; Zhang, Wei; Di, Qian; Duan, Ming-Hui; Ji, Wei; Cao, Xin-Xin; Zhou, Dao-Bin; Li, Jian // Annals of Hematology;Jul2014, Vol. 93 Issue 7, p1201 

    POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) syndrome is a rare plasma cell dyscrasia. Nearly all patients present with a λ-restricted monoclonal gammopathy. Most patients with POEMS syndrome have been reported to have a normal serum free light...

  • Protein Electrophoresis and Immunofixation for the Diagnosis of Monoclonal Gammopathies. Rajkumar, S. Vincent; Kyle, Robert A. // JAMA: Journal of the American Medical Association;11/26/2014, Vol. 312 Issue 20, p2160 

    The article reviews the application of urine protein electrophoresis and serum immunofixation in the case of a woman in her 70s who was diagnosed with monoclonal gammopathy of undetermined significance (MGUS). Data provided shows the patient's laboratory values and describes the characteristics...

  • Serial exome analysis of disease progression in premalignant gammopathies. Zhao, S; Choi, M; Heuck, C; Mane, S; Barlogie, B; Lifton, R P; Dhodapkar, M V // Leukemia (08876924);Jul2014, Vol. 28 Issue 7, p1548 

    The article discusses the study on the serial exome analysis of disease progression in premalignant gammopathies. It notes the multiple myeloma (MM) characterized by progressive growth of malignant plasma cells where nearly all cases are preceded by asymptomatic monoclonal gammopathies (AMGs)....

  • Auer rod-like inclusions in plasma cells in multiple myeloma. Wai Khoon Ho; Daniela Zantomio // Journal of Clinical Pathology;Jun2014, Vol. 67 Issue 6, p547 

    The article presents a case study of a female patient who presented to physicians with bone pain. A discussion of diagnostic testing which was conducted on the patient, and resulted in her receiving a diagnosis of multiple myeloma with Auer rod-like inclusions in her plasma cells, is presented.

  • A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined Significance. Kyle, Robert A.; Therneau, Terry M.; Rajkumar, S. Vincent; Offord, Janice R.; Larson, Dirk R.; Plevak, Matthew F.; Melton, L. Joseph // New England Journal of Medicine;2/21/2002, Vol. 346 Issue 8, p564 

    Background: A monoclonal gammopathy of undetermined significance (MGUS) occurs in up to 2 percent of persons 50 years of age or older. Reliable predictors of progression have not been identified, and information on prognosis is limited. Methods: We identified 1384 patients residing in...

  • Overview: Multiple lines of attack. Graham-Rowe, Duncan // Nature;12/15/2011 Supplement, Vol. 480 Issue 7377, pS34 

    The article offers information on the mechanism and treatment for multiple myeloma. It says that myeloma crowd out healthy plasma cells and interferes the production of other blood cell types and those involved in bone regeneration. It adds that the disease starts as a monoclonal gammopathy of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics